Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 9,823,000 | 9,048,000 | 8,386,000 | 7,477,000 | 7,380,000 |
| Cost of Goods | 2,813,000 | 2,593,000 | 2,424,000 | 2,173,000 | 2,210,000 |
| Gross Profit | 7,011,000 | 6,455,000 | 5,962,000 | 5,304,000 | 5,170,000 |
| Operating Expenses | 5,504,000 | 5,170,000 | 5,515,000 | 5,587,000 | 5,471,000 |
| Operating Income | 1,506,000 | 1,285,000 | 447,000 | -283,000 | -301,000 |
| Interest Expense | 241,000 | 229,000 | 233,000 | 284,000 | 216,000 |
| Other Income | 157,000 | -123,000 | -37,000 | -83,000 | 8,000 |
| Pre-tax Income | 1,422,000 | 933,000 | 177,000 | -650,000 | -509,000 |
| Income Tax | -249,000 | 828,000 | -170,000 | -411,000 | -390,000 |
| Net Income Continuous | 1,671,000 | 105,000 | 347,000 | -239,000 | -119,000 |
| Net Income | $1,671,000 | $105,000 | $347,000 | $-239,000 | $-119,000 |
| EPS Basic Total Ops | 1.21 | 0.08 | 0.26 | -0.18 | -0.09 |
| EPS Basic Continuous Ops | 1.21 | 0.08 | 0.26 | -0.18 | -0.09 |
| EPS Diluted Total Ops | 1.19 | 0.08 | 0.25 | -0.18 | -0.09 |
| EPS Diluted Continuous Ops | 1.19 | 0.08 | 0.25 | -0.18 | -0.09 |
| EPS Diluted Before Non-Recurring Items | 1.47 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $2,435,000 | $2,133,000 | $1,273,000 | $505,000 | $619,000 |